Gordon S, Pluddemann A, Martinez Estrada F
Large-scale trials including SUSTAIN-6 have demonstrated cardiovascular benefits and reduced major adverse cardiovascular events in high-risk patients
Semaglutide does not directly damage eye tissues
This review paper summarizes the research findings for NAD+ boosters and brain health, highlighting positive benefits for cognitive function and brain aging in animal models
(Manny) Simons, PhD MBA, CEO and Co-Founder Number of Employees: 100+ Stage: Acquired (by Eli Lilly) Financial Snapshot: Acquisition valued at $610 million ($487 million in cash, plus CVR) Notable Investors: 5AM Ventures, New Enterprise Associates (NEA) Key Products: Akouos does not yet market any products
Most carnitine is stored in muscle